Needed: Healthcare staff for the #COPCOV drug trial to prevent COVID-19.
There is increasing evidence that hydroxychloroquine has some preventive COVID-19 benefit. COPCOV is the world’s largest trial trying to determine: Can hydroxychloroquine help prevent COVID-19 in healthcare workers? To enrol in the UK, visit the COPCOV registration site.
The risk of Plasmodium vivax parasitaemia after P. falciparum malaria: An individual patient data meta-analysis from the WorldWide Antimalarial Resistance Network
Hossain MS. et al, (2020), PLOS Medicine, 17, e1003393 - e1003393
A Bayesian phase 2 model based adaptive design to optimise antivenom dosing: Application to a dose-finding trial for a novel Russell’s viper antivenom in Myanmar
Watson JA. et al, (2020), PLOS Neglected Tropical Diseases, 14, e0008109 - e0008109
The risk of adverse clinical outcomes following treatment of Plasmodium vivax malaria with and without primaquine in Papua, Indonesia
Thriemer K. et al, (2020), PLOS Neglected Tropical Diseases, 14, e0008838 - e0008838